封面
市場調查報告書
商品編碼
1612803

心臟監測與心律管理市場:按產品、最終用戶分類 - 全球預測 2025-2030 年

Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心臟監測和心律管理市場2023年估值為198億美元,預計到2024年將達到207.4億美元,複合年成長率為4.91%,預計到2030年將達到277.1億美元。

心臟監測和心律管理市場包括各種旨在診斷、管理和治療心血管疾病的設備和技術。由於心臟疾病仍然是全球發病的主要原因之一,因此需要持續監測患者和有效的疾病管理,這凸顯了對這些解決方案的需求。應用包括心律不整監測、遠端患者監護和術後護理,主要最終用途是醫院、診所和門診手術中心。關鍵的成長要素包括心血管疾病的盛行率不斷上升、醫療保健領域的物聯網和人工智慧等技術進步,以及個人主動管理健康意識的提高。此外,對家庭醫療保健解決方案的需求和遠端醫療服務的擴展導致遠端監控設備的快速採用,創造了巨大的成長機會。然而,設備成本高、法規結構複雜、報銷場景有限等挑戰可能會阻礙市場擴張。企業需要透過專注於具有成本效益的解決方案和安全的監管途徑來駕馭這些動態。利用巨量資料分析來改善預測診斷並提高不同監控系統之間的互通性是存在機會的。可提高準確性和患者舒適度的穿戴式技術創新可以提供顯著的競爭優勢。旨在使設備小型化同時保持效率的研究和開發工作也很有希望。此外,我們有潛力透過擴大與醫療保健提供者的夥伴關係和促進綜合護理服務來開拓新的細分市場。市場的本質是高度動態的,其特點是快速的技術轉變和對以患者為中心的解決方案的強烈關注。尋求發展的公司專注於整合先進的分析,透過使用者友好的介面加強患者的依從性,並不斷評估不斷變化的醫療保健環境,以跟上不斷變化的消費者需求和不斷變化的監管環境。避免這樣做。

主要市場統計
基準年[2023] 198億美元
預測年份 [2024] 207.4億美元
預測年份 [2030] 277.1億美元
複合年成長率(%) 4.91%

市場動態:快速發展的心臟監測和心律管理市場的關鍵市場洞察

心臟監測和節律管理市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 老年人口增加及心血管疾病發生率增加
    • 有利的政府法規和 CRM 報銷的可用性
    • 提高早期診斷和預防保健的意識
  • 市場限制因素
    • 與心臟監測和節律管理設備相關的高成本
  • 市場機會
    • 人們對穿戴式心臟監測設備的興趣日益濃厚
    • 持續開發先進心臟設備
  • 市場挑戰
    • 缺乏具有心電圖和心律專業知識的熟練專業人員

波特五力:引領心臟監測與心律管理市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解心臟監測和心律管理市場的外部影響

外部宏觀環境因素在塑造心臟監測和心律管理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟監測和心律管理市場的競爭格局

對心臟監測和節律管理市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟監測與心律管理市場供應商的績效評估

FPNV定位矩陣是評估心臟監測和心律管理市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心臟監測和心律管理市場的成功之路

對於希望加強在全球市場的影響力的公司來說,對心臟監測和心律管理市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加及心血管疾病發生率增加
      • 有利的 CRM 政府法規和報銷制度
      • 提高對早期診斷和預防性保健措施的認知
    • 抑制因素
      • 與心臟監測和節律管理設備相關的高成本
    • 機會
      • 對穿戴式心臟監測設備的興趣日益成長
      • 先進心臟設備的開發正在進行中
    • 任務
      • 缺乏具有心電圖和心率專業知識的熟練專業人員
  • 市場區隔分析
    • 產品:增加心臟監測設備在治療心臟相關疾病的使用
    • 最終使用者:高級護理醫院對心臟監測和節律管理的強烈需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心臟監測與心律管理市場:依產品

  • 心臟監測裝置
    • 心電圖
      • 心電圖監測
      • 靜態心電圖
      • 壓力心電圖
    • 心臟超音波圖
    • 心臟事件記錄器
    • 嵌入式循環錄音機
    • 移動心電遙測
  • 心率管理裝置
    • 心臟去顫器
      • 體外去顫心臟去顫器
      • 自動體外電擊器
      • 手動體外電擊器
      • 心臟去顫器
      • 植入式心臟整流去顫器
      • S-ICD
      • T-ICD
    • 循環錄音機
    • 心律調節器
      • 外部的
      • 凹入式

第7章心臟監測與心律管理市場:依最終使用者分類

  • 門診中心
  • 家庭保健
  • 醫院

第8章美洲心臟監測與心律管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太心臟監測與心律管理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的心臟監測和心律管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • Abbott Assert-IQ 心臟監測儀獲得 CE 標誌核准,用於增強心率管理
    • FDA核准Medtronic創新 Aurora EV-ICD 系統
    • 心臟監測的進展:波士頓科學公司 (Boston Scientific) 的 LUX-Dx II+ ICM 系統簡介
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACS Diagnostics by Applied Cardiac Systems Inc.
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • Baxter International Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Koninklijke Philips NV,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Qardio, Inc.
  • Schiller AG
  • Spandan
  • Tricog Health
  • Zoll Medical Corporation
Product Code: MRR-B812DD579A84

The Cardiac Monitoring & Cardiac Rhythm Management Market was valued at USD 19.80 billion in 2023, expected to reach USD 20.74 billion in 2024, and is projected to grow at a CAGR of 4.91%, to USD 27.71 billion by 2030.

The cardiac monitoring and cardiac rhythm management market encompasses a broad range of devices and technologies aimed at diagnosing, managing, and treating cardiovascular disorders. As cardiac diseases remain among the leading causes of morbidity globally, the necessity for these solutions is underscored by the need for continuous patient monitoring and efficient disease management. The application scope includes arrhythmia monitoring, remote patient monitoring, and post-operative care, catering to hospitals, clinics, and ambulatory surgical centers as primary end-use segments. Key growth influencers include the increasing prevalence of cardiovascular diseases, technological advancements like IoT and AI in healthcare, and rising awareness among individuals regarding proactive health management. Additionally, the adoption of remote monitoring devices has surged, driven by the demand for home healthcare solutions and the expansion of telemedicine services, presenting a significant growth opportunity. However, challenges such as high device costs, the complexity of regulatory frameworks, and limited reimbursement scenarios can impede market expansion. Companies must navigate these dynamics by focusing on cost-effective solutions and robust navigation of regulatory pathways. Opportunities lie in leveraging big data analytics for improved predictive diagnostics and enhancing interoperability among diverse monitoring systems. Innovating wearable technology with better accuracy and patient comfort could provide significant competitive advantages. Emphasizing R&D efforts toward miniaturization of devices while maintaining efficiency also holds promise. Further, expanding partnerships with healthcare providers to facilitate integrated care delivery could unlock new market segments. The nature of the market is highly dynamic, characterized by rapid technological shifts and a strong emphasis on patient-centered solutions. Businesses aiming for growth should concentrate on integrating advanced analytics, enhancing patient compliance through user-friendly interfaces, and continuously assessing the evolving healthcare landscape to keep abreast of shifting consumer demands and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 19.80 billion
Estimated Year [2024] USD 20.74 billion
Forecast Year [2030] USD 27.71 billion
CAGR (%) 4.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Monitoring & Cardiac Rhythm Management Market

The Cardiac Monitoring & Cardiac Rhythm Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population and incidence of cardiovascular diseases
    • Favorable government regulations and availability of reimbursement for CRM
    • Growing awareness towards early diagnosis and preventive healthcare measures
  • Market Restraints
    • High cost associated with cardiac monitoring and rhythm management devices
  • Market Opportunities
    • Increasing proclivity for wearable cardiac monitoring devices
    • Ongoing development for advanced cardiac devices
  • Market Challenges
    • Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Monitoring & Cardiac Rhythm Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Monitoring & Cardiac Rhythm Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Monitoring & Cardiac Rhythm Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Monitoring & Cardiac Rhythm Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Monitoring & Cardiac Rhythm Management Market

A detailed market share analysis in the Cardiac Monitoring & Cardiac Rhythm Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Monitoring & Cardiac Rhythm Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Monitoring & Cardiac Rhythm Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Monitoring & Cardiac Rhythm Management Market

A strategic analysis of the Cardiac Monitoring & Cardiac Rhythm Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Monitoring & Cardiac Rhythm Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Monitoring Devices and Cardiac Rhythm Management Devices. The Cardiac Monitoring Devices is further studied across ECG, Echocardiogram, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry. The ECG is further studied across Holter Monitors, Resting ECG, and Stress ECG. The Cardiac Rhythm Management Devices is further studied across Defibrillators, Loop Recorders, and Pacemaker. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The External Defibrillator is further studied across Automatic External Defibrillator, Manual External Defibrillator, and Wearable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillators is further studied across S-ICD and T-ICD. The Pacemaker is further studied across External and Implantable.
  • Based on End-User, market is studied across Ambulatory Center, Home Healthcare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population and incidence of cardiovascular diseases
      • 5.1.1.2. Favorable government regulations and availability of reimbursement for CRM
      • 5.1.1.3. Growing awareness towards early diagnosis and preventive healthcare measures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with cardiac monitoring and rhythm management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing proclivity for wearable cardiac monitoring devices
      • 5.1.3.2. Ongoing development for advanced cardiac devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of cardiac monitoring devices for treating heart-related conditions
    • 5.2.2. End-User: High need for cardiac monitoring & cardiac rhythm management across hospitals for providing advanced care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Monitoring & Cardiac Rhythm Management Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Monitoring Devices
    • 6.2.1. ECG
      • 6.2.1.1. Holter Monitors
      • 6.2.1.2. Resting ECG
      • 6.2.1.3. Stress ECG
    • 6.2.2. Echocardiogram
    • 6.2.3. Event Monitors
    • 6.2.4. Implantable Loop Recorders
    • 6.2.5. Mobile Cardiac Telemetry
  • 6.3. Cardiac Rhythm Management Devices
    • 6.3.1. Defibrillators
      • 6.3.1.1. External Defibrillator
      • 6.3.1.1.1. Automatic External Defibrillator
      • 6.3.1.1.2. Manual External Defibrillator
      • 6.3.1.1.3. Wearable Cardioverter Defibrillator
      • 6.3.1.2. Implantable Cardioverter Defibrillators
      • 6.3.1.2.1. S-ICD
      • 6.3.1.2.2. T-ICD
    • 6.3.2. Loop Recorders
    • 6.3.3. Pacemaker
      • 6.3.3.1. External
      • 6.3.3.2. Implantable

7. Cardiac Monitoring & Cardiac Rhythm Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Center
  • 7.3. Home Healthcare
  • 7.4. Hospitals

8. Americas Cardiac Monitoring & Cardiac Rhythm Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management
    • 11.3.2. FDA Approves Medtronic's Innovative Aurora EV-ICD System
    • 11.3.3. Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics by Applied Cardiac Systems Inc.
  • 3. Alivecor, Inc.
  • 4. Asahi Kasei Corporation
  • 5. Baxter International Inc.
  • 6. Biotronik SE & Co KG
  • 7. Boston Scientific Corporation
  • 8. BPL Medical Technologies Private Limited
  • 9. GE Healthcare
  • 10. HeartFlow Holding, Inc.
  • 11. Koninklijke Philips N.V.,
  • 12. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 13. Medtronic PLC
  • 14. Microport Scientific Corporation
  • 15. Nihon Kohden Corporation
  • 16. Qardio, Inc.
  • 17. Schiller AG
  • 18. Spandan
  • 19. Tricog Health
  • 20. Zoll Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY RESTING ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STRESS ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MOBILE CARDIAC TELEMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY S-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY T-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANC